Neuraminidase inhibitors: the story behind the Cochrane review
Downloadb5164.pdf (272.9Kb)
PUBLISHER_POLICY
Publisher Policy
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Terms of use
Metadata
Show full item recordAbstract
Although billions have been spent on oseltamivir in the face of pandemic influenza, the team updating the Cochrane review of neuraminidase inhibitors in healthy adults found that the public evidence base for this global public health drug was fragmented and inconsistent. Peter Doshi tells the story
Date issued
2009-12Department
Massachusetts Institute of Technology. Program in History, Anthropology, and Science, Technology, and SocietyJournal
British Medical Journal
Publisher
British Medical Association
Citation
Doshi, Peter. “Neuraminidase inhibitors--the story behind the Cochrane review.” BMJ 339.dec07_2 (2009): b5164.
Version: Final published version
ISSN
0959-8146